{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2022,9,24]],"date-time":"2022-09-24T05:12:01Z","timestamp":1663996321489},"reference-count":48,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2019,7,8]],"date-time":"2019-07-08T00:00:00Z","timestamp":1562544000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2019,7,8]],"date-time":"2019-07-08T00:00:00Z","timestamp":1562544000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Internist"],"published-print":{"date-parts":[[2019,8]]},"DOI":"10.1007\/s00108-019-0634-3","type":"journal-article","created":{"date-parts":[[2019,7,8]],"date-time":"2019-07-08T09:16:22Z","timestamp":1562577382000},"page":"821-839","update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Interstitielle Nephritis"],"prefix":"10.1007","volume":"60","author":[{"given":"Anna Laura","family":"Herzog","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kai","family":"Lopau","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2019,7,8]]},"reference":[{"key":"634_CR1","doi-asserted-by":"publisher","first-page":"1472","DOI":"10.1093\/ndt\/gfu326","volume":"30","author":"M Praga","year":"2015","unstructured":"Praga M, Sevillano A, Au\u00f1\u00f3n P, Gonz\u00e1lez E (2015) Changes in the aetiology, clinical presentation and management of acute interstitial nephritis, an increasingly common cause of acute kidney injury. Nephrol Dial Transplant 30:1472\u20131479","journal-title":"Nephrol Dial Transplant"},{"key":"634_CR2","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1093\/ndt\/gfs143","volume":"28","author":"M Goicoechea","year":"2013","unstructured":"Goicoechea M, Rivera F, L\u00f3pez-G\u00f3mez JM (2013) Spanish registry of glomerulonephritis. Increased prevalence of acute tubulointerstitial nephritis. Nephrol Dial Transplant 28:112\u2013115","journal-title":"Nephrol Dial Transplant"},{"key":"634_CR3","first-page":"e184852","volume":"1","author":"M Tonelli","year":"2018","unstructured":"Tonelli M, Wiebe N, Manns BJ et\u00a0al (2018) Comparison of the complexity of patients seen by different medical subspecialists in a\u00a0universal health care system. JAMA 1:e184852","journal-title":"JAMA"},{"key":"634_CR4","doi-asserted-by":"publisher","first-page":"956","DOI":"10.1038\/ki.2010.89","volume":"77","author":"M Praga","year":"2010","unstructured":"Praga M, Gonz\u00e1lez E (2010) Acute interstitial nephritis. Kidney Int 77:956\u2013961","journal-title":"Kidney Int"},{"key":"634_CR5","doi-asserted-by":"publisher","first-page":"e0204231","DOI":"10.1371\/journal.pone.0204231","volume":"13","author":"A Rodr\u00edguez-Poncelas","year":"2018","unstructured":"Rodr\u00edguez-Poncelas A, Barcel\u00f3 MA, Saez M, Coll-de-Tuero G (2018) Duration and dosing of Proton Pump Inhibitors associated with high incidence of chronic kidney disease in population-based cohort. PLoS ONE 13:e204231","journal-title":"PLoS ONE"},{"key":"634_CR6","first-page":"3","volume":"9","author":"N Krishnan","year":"2015","unstructured":"Krishnan N, Perazella MA (2015) Drug-induced acute interstitial nephritis: pathology, pathogenesis, and treatment. Iran J Kidney Dis 9:3\u201313","journal-title":"Iran J Kidney Dis"},{"key":"634_CR7","doi-asserted-by":"publisher","first-page":"461","DOI":"10.1038\/nrneph.2010.71","volume":"6","author":"MA Perazella","year":"2010","unstructured":"Perazella MA, Markowitz GS (2010) Drug-induced acute interstitial nephritis. Nat Rev Nephrol 6:461\u2013470","journal-title":"Nat Rev Nephrol"},{"key":"634_CR8","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1056\/NEJM197408222910803","volume":"291","author":"WA Border","year":"1974","unstructured":"Border WA, Lehman DH, Egan JD, Sass HJ, Glode JE, Wilson CB (1974) Antitubular basement-membrane antibodies in methicillin-associated interstitial nephritis. N\u00a0Engl J Med 291:381\u2013384","journal-title":"N Engl J Med"},{"key":"634_CR9","doi-asserted-by":"publisher","first-page":"649","DOI":"10.1053\/j.ajkd.2013.02.349","volume":"61","author":"PM Palevsky","year":"2013","unstructured":"Palevsky PM, Liu KD, Brophy PD et\u00a0al (2013) KDOQI US commentary on the 2012 KDIGO clinical practice guideline for acute kidney injury. Am J Kidney Dis 61:649\u2013672","journal-title":"Am J Kidney Dis"},{"key":"634_CR10","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1093\/ndt\/gfg464","volume":"19","author":"RJ Baker","year":"2004","unstructured":"Baker RJ, Pusey CD (2004) The changing profile of acute tubulointerstitial nephritis. Nephrol Dial Transplant 19:8\u201311","journal-title":"Nephrol Dial Transplant"},{"key":"634_CR11","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1016\/j.mayocp.2017.08.024","volume":"93","author":"S Farid","year":"2018","unstructured":"Farid S, Mahmood M, Saleh AOM et al (2018) Clinical manifestations and outcomes of fluoroquinolone-related acute interstitial nephritis. Mayo Clin Proc 93:25\u201331","journal-title":"Mayo Clin Proc"},{"key":"634_CR12","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1159\/000354088","volume":"38","author":"H Xie","year":"2013","unstructured":"Xie H, Chen H, Hu Y et al (2013) Clindamycin-induced acute kidney injury: large biopsy case series. Am J Nephrol 38:179\u2013183","journal-title":"Am J Nephrol"},{"key":"634_CR13","volume-title":"Mitteilungen: Arznei-mittel-kommission der deutschen \u00c4rzteschaft \u201eUAW-News\u201c \u2013 International Nephrotisches Syndrom und interstitielle Nephritis unter\u2026 [Internet]. Deutsches \u00c4rzteblatt","author":"\u00c4rzteblatt D\u00c4G Redaktion Deutsches","year":"2004","unstructured":"\u00c4rzteblatt D\u00c4G Redaktion Deutsches (2004) Mitteilungen: Arznei-mittel-kommission der deutschen \u00c4rzteschaft \u201eUAW-News\u201c \u2013 International Nephrotisches Syndrom und interstitielle Nephritis unter\u2026 [Internet]. Deutsches \u00c4rzteblatt. https:\/\/www.aerzteblatt.de\/archiv\/43475\/Mitteilungen-Arznei-mittel-kommission-der-deutschen-Aerzteschaft-UAW-News-International-Nephrotisches-Syndrom-und-interstitielle-Nephritis-unter-Celecoxib . Zugegriffen: 11. M\u00e4rz 2019"},{"key":"634_CR14","doi-asserted-by":"publisher","first-page":"1841","DOI":"10.2215\/CJN.08620813","volume":"8","author":"MA Perazella","year":"2013","unstructured":"Perazella MA, Bomback AS (2013) Urinary eosinophils in AIN: farewell to an old biomarker? Clin J Am Soc Nephrol 8:1841\u20131843","journal-title":"Clin. J. Am. Soc. Nephrol."},{"issue":"3","key":"634_CR15","doi-asserted-by":"publisher","first-page":"149","DOI":"10.5414\/CN10838","volume":"82","author":"R Raghavan","year":"2014","unstructured":"Raghavan R, Eknoyan G (2014) Acute interstitial nephritis\u2014a\u00a0reappraisal and update. Clin Nephrol. 82(3):149\u2013162","journal-title":"Clin Nephrol"},{"key":"634_CR16","doi-asserted-by":"publisher","first-page":"837","DOI":"10.1038\/ki.2014.74","volume":"86","author":"M-L Blank","year":"2014","unstructured":"Blank M\u2011L, Parkin L, Paul C, Herbison P (2014) A nationwide nested case-control study indicates an increased risk of acute interstitial nephritis with proton pump inhibitor use. Kidney Int 86:837\u2013844","journal-title":"Kidney Int"},{"key":"634_CR17","doi-asserted-by":"publisher","first-page":"281","DOI":"10.4103\/0971-4065.147766","volume":"25","author":"R Ramachandran","year":"2015","unstructured":"Ramachandran R, Kumar K, Nada R, Jha V, Gupta KL, Kohli HS (2015) Drug-induced acute interstitial nephritis: a clinicopathological study and comparative trial of steroid regimens. Indian J Nephrol 25:281","journal-title":"Indian J Nephrol"},{"key":"634_CR18","volume-title":"Verordnung von Protonenpumpeninhibitoren deutlich gestiegen. Deutsches \u00c4rzteblatt 2017","author":"\u00c4D\u00c4G Redaktion Deutsches","year":"2017","unstructured":"Redaktion Deutsches \u00c4D\u00c4G Verordnung von Protonenpumpeninhibitoren deutlich gestiegen. Deutsches \u00c4rzteblatt 2017. https:\/\/www.aerzteblatt.de\/nachrichten\/77288\/Verordnung-von-Protonenpumpeninhibitoren-deutlich-gestiegen . Zugegriffen: 13. M\u00e4rz 2019"},{"key":"634_CR19","doi-asserted-by":"publisher","first-page":"220","DOI":"10.1097\/MPG.0b013e3182a3b04e","volume":"58","author":"P De Bruyne","year":"2014","unstructured":"De Bruyne P, Christiaens T, Vander Stichele R, Van Winckel M (2014) Changes in prescription patterns of acid-suppressant medications by Belgian pediatricians: analysis of the national database, [1997\u20132009. J\u00a0Pediatr Gastroenterol Nutr 58:220\u2013225","journal-title":"J Pediatr Gastroenterol Nutr"},{"key":"634_CR20","doi-asserted-by":"publisher","first-page":"238","DOI":"10.1001\/jamainternmed.2015.7193","volume":"176","author":"B Lazarus","year":"2016","unstructured":"Lazarus B, Chen Y, Wilson FP et\u00a0al (2016) Proton pump inhibitor use and the risk of chronic kidney disease. JAMA Intern Med 176:238","journal-title":"JAMA Intern Med"},{"key":"634_CR21","doi-asserted-by":"publisher","first-page":"945","DOI":"10.1111\/j.1365-2036.2006.03084.x","volume":"24","author":"E Bj\u00f6rnsson","year":"2006","unstructured":"Bj\u00f6rnsson E, Abrahamsson H, Simr\u00e9n M et al (2006) Discontinuation of proton pump inhibitors in patients on long-term therapy: a\u00a0double-blind, placebo-controlled trial. Aliment Pharmacol Ther 24:945\u2013954","journal-title":"Aliment Pharmacol Ther"},{"key":"634_CR22","doi-asserted-by":"publisher","first-page":"f3646","DOI":"10.1136\/bmj.f3646","volume":"346","author":"A Cipriani","year":"2013","unstructured":"Cipriani A, Hawton K, Stockton S, Geddes JR (2013) Lithium in the prevention of suicide in mood disorders: updated systematic review and meta-analysis. BMJ 346:f3646","journal-title":"BMJ"},{"key":"634_CR23","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1038\/ki.2009.433","volume":"77","author":"H Bendz","year":"2010","unstructured":"Bendz H, Sch\u00f6n S, Attman P\u2011O, Aurell M (2010) Renal failure occurs in chronic lithium treatment but is uncommon. Kidney Int 77:219\u2013224","journal-title":"Kidney Int"},{"key":"634_CR24","doi-asserted-by":"crossref","first-page":"1439","DOI":"10.1681\/ASN.V1181439","volume":"11","author":"GS Markowitz","year":"2000","unstructured":"Markowitz GS, Radhakrishnan J, Kambham N, Valeri AM, Hines WH, D\u2019Agati VD (2000) Lithium nephrotoxicity: a\u00a0progressive combined glomerular and tubulointerstitial nephropathy. J\u00a0Am Soc Nephrol 11:1439\u20131448","journal-title":"J. Am. Soc. Nephrol."},{"key":"634_CR25","doi-asserted-by":"publisher","first-page":"1734","DOI":"10.1126\/science.271.5256.1734","volume":"271","author":"DR Leach","year":"1996","unstructured":"Leach DR, Krummel MF, Allison JP (1996) Enhancement of antitumor immunity by CTLA-4 blockade. Science 271:1734\u20131736","journal-title":"Science"},{"key":"634_CR26","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1159\/000455014","volume":"45","author":"R Wanchoo","year":"2017","unstructured":"Wanchoo R, Karam S, Uppal NN et\u00a0al (2017) Adverse renal effects of immune checkpoint inhibitors: a narrative review. Am J Nephrol 45:160\u2013169","journal-title":"Am J Nephrol"},{"key":"634_CR27","doi-asserted-by":"publisher","first-page":"1457","DOI":"10.1038\/bjc.2016.358","volume":"115","author":"J Belliere","year":"2016","unstructured":"Belliere J, Meyer N, Mazieres J et\u00a0al (2016) Acute interstitial nephritis related to immune checkpoint inhibitors. Br J Cancer 115:1457\u20131461","journal-title":"Br J Cancer"},{"key":"634_CR28","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1097\/QCO.0000000000000227","volume":"29","author":"C Schneeberger","year":"2016","unstructured":"Schneeberger C, Holleman F, Geerlings SE (2016) Febrile urinary tract infections: pyelonephritis and urosepsis. Curr Opin Infect Dis 29:80\u201385","journal-title":"Curr Opin Infect Dis"},{"key":"634_CR29","doi-asserted-by":"publisher","first-page":"e0191066","DOI":"10.1371\/journal.pone.0191066","volume":"13","author":"A Artero","year":"2018","unstructured":"Artero A, Inglada L, G\u00f3mez-Belda A et al (2018) The clinical impact of bacteremia on outcomes in elderly patients with pyelonephritis or urinary sepsis: a prospective multicenter study. PLoS ONE 13:e191066","journal-title":"PLoS ONE"},{"key":"634_CR30","first-page":"285","volume":"20","author":"VY Chung","year":"2014","unstructured":"Chung VY, Tai CK, Fan CW, Tang CN (2014) Severe acute pyelonephritis: a\u00a0review of clinical outcome and risk factors for mortality. Hong Kong Med J 20:285\u2013289","journal-title":"Hong Kong. Med. J."},{"key":"634_CR31","volume-title":"Pathophysiologie","author":"UR F\u00f6lsch","year":"2013","unstructured":"F\u00f6lsch UR, Kochsiek K, Schmidt RF (2013) Pathophysiologie. Springer, Berlin Heidelberg"},{"key":"634_CR32","volume-title":"Interdisziplin\u00e4re S3 Leitlinie: Epidemiologie, Diagnostik, Therapie, Pr\u00e4vention und Management unkomplizierter, bakterieller, ambulant erworbener Harnwegsinfektionen bei erwachsenen Patienten. Langversion 1.1-2, 2017 AWMF Registernummer: 043\/044","author":"DGU Leitlinienprogramm","year":"2017","unstructured":"Leitlinienprogramm DGU (2017) Interdisziplin\u00e4re S3 Leitlinie: Epidemiologie, Diagnostik, Therapie, Pr\u00e4vention und Management unkomplizierter, bakterieller, ambulant erworbener Harnwegsinfektionen bei erwachsenen Patienten. Langversion 1.1-2, 2017 AWMF Registernummer: 043\/044. http:\/\/www.awmf.org\/uploads\/tx_szleitlinien\/043-044l_S3_Harnwegsinfektionen pdf. Zugegriffen: 20. M\u00e4rz 2019"},{"key":"634_CR33","first-page":"4","volume":"135","author":"L Li","year":"2011","unstructured":"Li L, Parwani AV (2011) Xanthogranulomatous pyelonephritis. Arch Pathol Lab Med 135:4","journal-title":"Arch Pathol Lab Med"},{"key":"634_CR34","doi-asserted-by":"publisher","first-page":"643","DOI":"10.1007\/s13244-018-0631-4","volume":"9","author":"C Sang\u00fcesa Nebot","year":"2018","unstructured":"Sang\u00fcesa Nebot C, Pic\u00f3 Aliaga S, Serrano Durb\u00e1 A, Roca MJ (2018) Xantogranulomatous pyeloneprhritis in children. Insights Imaging 9:643\u2013651","journal-title":"Insights Imaging"},{"key":"634_CR35","first-page":"652","volume":"305","author":"A Jurke","year":"2015","unstructured":"Jurke A, Bannert N, Brehm K et al (2015) Serological survey of Bartonella spp., Borrelia burgdorferi, Brucella spp., Coxiella burnetii, Francisella tularensis, Leptospira spp., Echinococcus, Hanta\u2011, TBE- and XMR-virus infection in employees of two forestry enterprises in North Rhine-Westphalia, Germany, 2011\u20132013. Zentralbl Bakteriol 305:652\u2013662","journal-title":"Zentralbl Bakteriol"},{"key":"634_CR36","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1093\/ndt\/gfu319","volume":"30","author":"J Latus","year":"2015","unstructured":"Latus J, Schwab M, Tacconelli E et al (2015) Acute kidney injury and tools for risk-stratification in 456 patients with hantavirus-induced nephropathia epidemica. Nephrol Dial Transplant 30:245\u2013251","journal-title":"Nephrol Dial Transplant"},{"key":"634_CR37","doi-asserted-by":"publisher","first-page":"549","DOI":"10.1089\/vbz.2009.0138","volume":"10","author":"GE Olsson","year":"2010","unstructured":"Olsson GE, Leirs H, Henttonen H (2010) Hantaviruses and their hosts in europe: reservoirs here and there, but not everywhere? Vector Borne Zoonotic Dis 10:549\u2013561","journal-title":"Vector. Borne Zoonotic Dis."},{"key":"634_CR38","doi-asserted-by":"publisher","first-page":"995","DOI":"10.1016\/j.ophtha.2007.01.002","volume":"114","author":"F Mackensen","year":"2007","unstructured":"Mackensen F, Smith JR, Rosenbaum JT (2007) Enhanced recognition, treatment, and prognosis of tubulointerstitial nephritis and uveitis syndrome. Ophthalmology 114:995\u2013999","journal-title":"Ophthalmology"},{"key":"634_CR39","volume-title":"Tubulointerstitial nephritis and uveitis (TINU) syndrome: a\u00a0systematic review of its epidemiology, demographics and risk factors. Orphanet Journal of Rare Diseases","author":"LO Okafor","year":"2017","unstructured":"Okafor LO, Hewins P, Murray PI, Denniston AK (2017) Tubulointerstitial nephritis and uveitis (TINU) syndrome: a\u00a0systematic review of its epidemiology, demographics and risk factors. Orphanet Journal of Rare Diseases. https:\/\/www.ncbi.nlm.nih.gov\/pmc\/articles\/PMC5513333\/ . Zugegriffen: 20. M\u00e4rz 2019"},{"key":"634_CR40","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1016\/S0039-6257(01)00261-2","volume":"46","author":"JT Mandeville","year":"2001","unstructured":"Mandeville JT, Levinson RD, Holland GN (2001) The tubulointerstitial nephritis and uveitis syndrome. Surv Ophthalmol 46:195\u2013208","journal-title":"Surv Ophthalmol"},{"key":"634_CR41","doi-asserted-by":"publisher","first-page":"172","DOI":"10.1016\/S0272-6386(12)80178-8","volume":"24","author":"M Depierreux","year":"1994","unstructured":"Depierreux M, Van Damme B, Vanden Houte K, Vanherweghem JL (1994) Pathologic aspects of a\u00a0newly described nephropathy related to the prolonged use of Chinese herbs. Am J Kidney Dis 24:172\u2013180","journal-title":"Am J Kidney Dis"},{"key":"634_CR42","doi-asserted-by":"publisher","first-page":"157","DOI":"10.4103\/1319-2442.252906","volume":"30","author":"M Surendra","year":"2019","unstructured":"Surendra M, Raju S, Chandragiri S, Uppin MS, Raju N (2019) Steroid therapy in drug induced acute interstitial nephritis- Retrospective analysis of 83 cases. Saudi J Kidney Dis Transplant 30:157\u2013165","journal-title":"Saudi J Kidney Dis Transplant"},{"key":"634_CR43","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1007\/s00467-008-1074-9","volume":"24","author":"SP Andreoli","year":"2009","unstructured":"Andreoli SP (2009) Acute kidney injury in children. Pediatr Nephrol 24:253\u2013263","journal-title":"Pediatr Nephrol"},{"key":"634_CR44","doi-asserted-by":"publisher","first-page":"558","DOI":"10.1053\/j.ajkd.2014.04.027","volume":"64","author":"AK Muriithi","year":"2014","unstructured":"Muriithi AK, Leung N, Valeri AM et al (2014) Biopsy-proven acute interstitial nephritis, 1993\u20132011: a\u00a0case\u00a0series. Am J Kidney Dis 64:558\u2013566","journal-title":"Am J Kidney Dis"},{"key":"634_CR45","doi-asserted-by":"publisher","first-page":"940","DOI":"10.1038\/sj.ki.5002776","volume":"73","author":"E Gonz\u00e1lez","year":"2008","unstructured":"Gonz\u00e1lez E, Guti\u00e9rrez E, Galeano C et al (2008) Early steroid treatment improves the recovery of renal function in patients with drug-induced acute interstitial nephritis. Kidney Int 73:940\u2013946","journal-title":"Kidney Int"},{"key":"634_CR46","doi-asserted-by":"publisher","first-page":"1253","DOI":"10.1007\/s00467-013-2476-x","volume":"28","author":"T Jahnukainen","year":"2013","unstructured":"Jahnukainen T, Saarela V, Arikoski P et\u00a0al (2013) Prednisone in the treatment of tubulointerstitial nephritis in children. Pediatr Nephrol 28:1253\u20131260","journal-title":"Pediatr Nephrol"},{"key":"634_CR47","doi-asserted-by":"publisher","first-page":"c42","DOI":"10.1159\/000342385","volume":"121","author":"E Guti\u00e9rrez","year":"2012","unstructured":"Guti\u00e9rrez E, Egido J, Rubio-Navarro A et al (2012) Oxidative stress, macrophage infiltration and CD163 expression are determinants of long-term renal outcome in macrohematuria-induced acute kidney injury of IgA nephropathy. Nephron Clin Pract 121:c42\u2013c53","journal-title":"Nephron Clin Pract"},{"key":"634_CR48","doi-asserted-by":"publisher","first-page":"138","DOI":"10.1016\/j.ekir.2016.09.059","volume":"2","author":"T Shao","year":"2016","unstructured":"Shao T, Weinstein J, Jothy S, Goldstein M (2016) Severe acute interstitial nephritis: response to therapy with antithymocyte\u00a0globulin. Kidney Int Rep 2:138\u2013141","journal-title":"Kidney Int Rep"}],"container-title":["Der Internist"],"original-title":[],"language":"de","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00108-019-0634-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00108-019-0634-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00108-019-0634-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,9,23]],"date-time":"2022-09-23T04:26:11Z","timestamp":1663907171000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00108-019-0634-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,7,8]]},"references-count":48,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2019,8]]}},"alternative-id":["634"],"URL":"https:\/\/doi.org\/10.1007\/s00108-019-0634-3","relation":{},"ISSN":["0020-9554","1432-1289"],"issn-type":[{"value":"0020-9554","type":"print"},{"value":"1432-1289","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,7,8]]},"assertion":[{"value":"8 July 2019","order":1,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Einhaltung ethischer Richtlinien"}},{"value":"Gem\u00e4\u00df den Richtlinien des Springer Medizin Verlags werden Autoren und Wissenschaftliche Leitung im Rahmen der Manuskripterstellung und Manuskriptfreigabe aufgefordert, eine vollst\u00e4ndige Erkl\u00e4rung zu ihren finanziellen und nichtfinanziellen Interessen abzugeben.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Interessenkonflikt"}},{"value":"<b>A.L.\u00a0Herzog<\/b>: Finanzielle Interessen: Reisekostenerstattung und Kongressgeb\u00fchren: Deutsche Transplantationsgesellschaft (DTG) 2014 Astellas, DTG 2015 Astellas, American Transplant Congress (ATC) 2016 Astellas, DTG 2016 Astellas, 2017 Stockholm Tx-Meeting Astellas, DTG 2017 Pfizer, DTG 2018 Astellas, DTG 2019 Astellas. Nichtfinanzielle Interessen: Angestellte Fach\u00e4rztin, gesch\u00e4ftsf\u00fchrende \u00c4rztin Transplantationszentrum UKW | Universit\u00e4tsklinikum W\u00fcrzburg, Transplantationszentrum, Oberd\u00fcrrbacherstr.\u00a06, 97080 W\u00fcrzburg. | Mitgliedschaft Deutsche Transplantationsgesellschaft (DTG), Deutsche Gesellschaft f\u00fcr Innere Medizin (DGIM), European Society of Transplantation (ESOT). <b>K.\u00a0Lopau<\/b>: Finanzielle Interessen: Vortragshonorare: Fa. Novartis, Boehringer Ingelheim, Medica Education\/Messe D\u00fcsseldorf, Fresenius Medical Care, Roche Diagnostics | Reise- und \u00dcbernachtungskosten\/Kongressteilnahmegeb\u00fchren: Fa. Astellas, Alexion. Nichtfinanzielle Interessen: Angestellter Internist \u2013 Nephrologe, Medizinische Universit\u00e4tsklinik und Poliklinik\u00a0I, W\u00fcrzburg | Mitgliedschaft: Deutsche Gesellschaft f\u00fcr Innere Medizin (DGIM), Deutsche Transplantationsgesellschaft (DTG).","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Autoren"}},{"value":"Die vollst\u00e4ndige Erkl\u00e4rung zum Interessenkonflikt der Wissenschaftlichen Leitung finden Sie am Kurs der zertifizierten Fortbildung aufExternalRef removed.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Wissenschaftliche Leitung"}},{"value":"erkl\u00e4rt, dass f\u00fcr die Publikation dieser CME-Fortbildung keine Sponsorengelder an den Verlag flie\u00dfen.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Der Verlag"}},{"value":"F\u00fcr diesen Beitrag wurden von den Autoren keine Studien an Menschen oder Tieren durchgef\u00fchrt. F\u00fcr die aufgef\u00fchrten Studien gelten die jeweils dort angegebenen ethischen Richtlinien.","order":6,"name":"Ethics","group":{"name":"EthicsHeading","label":"Der Verlag"}}]}}